A metastasis biomarker (MetaSite <i>Breast</i>™ Score) is associated with distant recurrence in hormone receptor-positive, HER2-negative early-stage breast cancer.

NPJ Breast Cancer · 2017 · PMC5678158 · PMID 29138761

Europe PMC DOI

hedged sentence

0.0600

closest p · 1.2× alpha

0.0600

boldest claim

The sentences

nearly significantp = 0.06so close (0.05 < p ≤ 0.1)

A nearly significant association was also noted between MetaSite Score and breast cancer specific survival ( p = 0.06) but not overall survival (OS) ( p = 0.21) in the HR+/HER2- group in the time-varying coefficient model, which may be explained by the high proportion of deaths in this group that were not due to breast cancer (48/85 [56%]).

also in 3,279 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.